Article
Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia.
Nutrition, metabolism, and cardiovascular diseases : NMCD - 6 May 2021
Climent Elisenda, Marco-Benedí Victoria, Benaiges David, Pintó Xavier, Suárez-Tembra Manuel, Plana Núria, Lafuente Hannia, Ortega-Martínez de Victoria Emilio, Brea-Hernando Ángel, Vila Àlex, Civeira Fernando, Pedro-Botet Juan
Abstract excerpt
BACKGROUND AND AIMS: Cardiovascular risk in heterozygous familial hypercholesterolaemia (HeFH) is driven by LDL cholesterol levels. Since lipid response to statin therapy presents individual variation, this study aimed to compare mean LDL and non-HDL cholesterol reductions and their variability achieved with different types and doses of the most frequently prescribed statins. METHODS AND RESULTS: Among primary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.